Cargando…
Affinity, potency, efficacy, and selectivity of neurokinin A analogs at human recombinant NK2 and NK1 receptors
A series of peptide NK2 receptor agonists was evaluated for affinity, potency, efficacy, and selectivity at human recombinant NK2 and NK1 receptors expressed in CHO cells to identify compounds with the greatest separation between NK2 and NK1 receptor agonist activity. Binding studies were performed...
Autores principales: | Rupniak, Nadia M. J., Perdona, Elisabetta, Griffante, Cristiana, Cavallini, Palmina, Sava, Anna, Ricca, Daniel J., Thor, Karl B., Burgard, Edward C., Corsi, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201908/ https://www.ncbi.nlm.nih.gov/pubmed/30359406 http://dx.doi.org/10.1371/journal.pone.0205894 |
Ejemplares similares
-
Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation
por: Jones, Sarah, et al.
Publicado: (2008) -
Capsaicin-Mediated Neurogenic Vasodilatation in Neurokinin-1, NK(1), Receptor Knockout Mice
por: Grant, A. D., et al.
Publicado: (2001) -
Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK(1)) receptor antagonists
por: Bošnjak, Snežana M., et al.
Publicado: (2017) -
Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics
por: Gadais, Charlène, et al.
Publicado: (2021) -
Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer Resistance
por: García-Aranda, Marilina, et al.
Publicado: (2022)